Actavis (NYSE: ACT) confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE